ISPOR 15th Annual European Congress Disclosure Information for Research Presentations

Download ISPOR 15th Annual European Congress Disclosure Information for Research Presentations

Post on 30-Dec-2016




5 download

Embed Size (px)


<ul><li><p>ISPOR 15TH ANNUAL EUROPEAN CONGRESS DISCLOSURE INFORMATION FOR RESEARCH PRESENTATIONS</p><p>The International Society for Pharmacoeconomics and Outcomes Research asked all abstract contributors to disclose financial support for their research.The following financial support was declared:</p><p>ReferenceCode Financial Support</p><p>ReferenceCode Financial Support</p><p>CA1 French National Cancer Institute (INCa), Boulogne-Billancourt, FranceCA2 Costello Medical Consulting Ltd., Cambridge, UKCA3 NoneCA4 Bristol Myers-Squibb, Uxbridge, UKCL1 NoneCL2 Millennium, Boston, MA, USACL3 NoneCL4 PFIZER Italia S.R.L., Roma, ItalyCV1 British Heart Foundation, London, UKCV2 The Center for Translational Molecular Medicine, Eindhoven, NetherlandsCV3 Sorin Cardio Biomedica, Saluggia, ItalyCV4 Italian Ministry of Health, Rome, Italy; Regione Lombardia, Milan, ItalyDB1 NoneDB2 NovoNordisk, Warsaw, PolandDB3 Novartis Farmaceutica, Barcelona, SpainDB4 Novo Nordisk, Copenhagen, DenmarkDU1 NoneDU2 NoneDU3 H. Lundbeck A/S, Copenhagen, DenmarkDU4 Serbian Ministry of science, Belgrade, Serbia and MontenegroMA1 NoneMA2 UCB Pharma, Slough, UKMA3 JANSSEN-CILAG, SAO PAULO, BrazilMA4 Teva Pharmaceuticals, Horsham, PA, USAMO1 Lundbeck, Issy les Moulineaux, FranceMO2 GlaxoSmithKline, Zeist, NetherlandsMO3 COMET Center ONCOTYROL, Innsbruck, Austria; Tiroler Zukunftsstiftung/</p><p>Standortagentur Tirol (SAT), Innsbruck, AustriaMO4 Pfizer UK, Tadworth, UKNI1 NoneNI2 Costello Medical Consulting Ltd, Cambridge, UKNI3 NoneNI4 NonePA1 Double Helix Consulting, London, UKPA2 Ministry of Health, rome, ItalyPA3 CEESTAHC, Krakow, PolandPA4 Baxter Healthcare Corporation, Braine lAlleud, BelgiumPCN1 Eisai, Inc, Woodcliff Lake, NJ, USAPCN2 Janssen-Cilag, Neuss, ME, GermanyPCN3 Amgen Inc., Thousand Oaks, CA, USAPCN4 FFG-sterreichische Forschungsfrderungsgesellschaft, Wien, AustriaPCN5 Sanofi Aventis Deutschland GmbH, Frankfurt, GermanyPCN6 Netherlands Organisation for Health Research and Development (ZonMw),</p><p>Den Haag, Netherlands; Roche Nederland B.V., Woerden, Netherlands; PfizerB.V., Capelle aan den IJssel, Netherlands</p><p>PCN7 Eli Lilly and Company, Indianapolis, IN, USAPCN8 Pfizer Global Pharmaceuticals, New York, NY, USAPCN9 Amgen Inc, Thousand Oaks, CA, USAPCN10 Eisai, Inc, Woodcliff Lake, NJ, USAPCN11 Celgene, Summit, NJ, USAPCN13 GlaxoSmithKline, Zeist, NetherlandsPCN14 NonePCN15 Agency for Health Technology Assessment In Poland (AHTAPol), Warsaw,</p><p>PolandPCN16 Pfizer Poland, Warsaw, PolandPCN17 Roche Farmaceutica QUmica, Lda., Amadora, PortugalPCN19 NonePCN20 National Evidence-based Healthcare Collaborating Agency, Seoul, South</p><p>KoreaPCN21 Bristol Myers Squibb, Sao Paulo, BrazilPCN22 NonePCN23 NonePCN24 Pfizer, New York, NY, USAPCN25 Roche, Moscow, RussiaPCN26 NonePCN27 Janssen-Cilag GmbH, Neuss, GermanyPCN28 NonePCN29 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPCN30 NonePCN31 NonePCN32 NonePCN33 NonePCN34 Lundbeck Canada, Montreal, QC, CanadaPCN35 Sanofi, Chilly Mazarin, France</p><p>PCN36 Pliva Croatia Ltd., Zagreb, CroatiaPCN37 NonePCN38 United BioSource Corporation, Bethesda, MD, USAPCN39 Roche Products Limited, Welwyn Garden City, UKPCN40 NonePCN41 Nestle Health Science, Vevey, SwitzerlandPCN42 French National Cancer Institute (INCa), Boulogne-Billancourt, FrancePCN43 NonePCN44 Roche Austria, Vienna, AustriaPCN45 William Harvey Research Institute, London, UKPCN46 Janssen, Madrid, SpainPCN47 Deutsche Krebshilfe e. V., Bonn, GermanyPCN48 Sanofi Pasteur MSD, Maidenhead, UKPCN49 Brystol-Myers Squibb, Moscow, RussiaPCN50 Roche, Basel, SwitzerlandPCN51 Genentech, South San Francisco, CA, USAPCN52 Sanofi Pasteur MSD, Maidenhead, UKPCN53 NonePCN54 NonePCN55 NonePCN56 Sanofi Pasteur MSD, Maidenhead, UKPCN57 Janssen, the pharmaceutical division of Johnson &amp; Johnson LLC, Moscow,</p><p>Russia; Ferring Pharmaceuticals, LLC, Moscow, RussiaPCN58 The research is supported by the German Federal Ministry of Education and</p><p>Research (BMBF), project grant No. 01EX1013B as part of the Centre ofExcellence for Medical Technology, Bonn, Germany</p><p>PCN59 Novartis Pharma AG, Basel, SwitzerlandPCN60 NonePCN61 Bristol Myers Squibb, Sao Paulo, BrazilPCN62 Caris Life Sciences, Irving, TX, USAPCN63 Bristol-Myers Squibb, Madrid, SpainPCN64 Novartis Biociencias SA, Sao Paulo, BrazilPCN65 Expanded Program on Immunization, Colombian Ministry of Health and Social</p><p>Protection, Bogota, ColombiaPCN66 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPCN67 NonePCN68 ZONMW, Den Haag, Netherlands; Roche B.V., Woerden, NetherlandsPCN69 NonePCN70 Ferring International Center SA , Saint-Prex, SwitzerlandPCN71 NonePCN72 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPCN73 Pfizer S.A. de C.V., Mexico City, MexicoPCN74 Baxter Healthcare SA, Zurich, SwitzerlandPCN75 Pfizer AB, Stockholm, SwedenPCN76 Roche Farma S.A., Madrid, SpainPCN77 NonePCN78 Sanofi Espana, Barcelona, SpainPCN79 elgene, Moscow, RussiaPCN80 Bristol Mysers-Squibb, Uxbridge, UKPCN81 GlaxoSmithKline, Uxbridge, UKPCN82 Roche Farma S.A., Madrid, SpainPCN83 NonePCN84 Janssen Cilag Pharmaceutical SACI, Athens, GreecePCN85 NonePCN86 JANSSEN-CILAG, SAO PAULO, BrazilPCN87 Roche, Mexico City, MexicoPCN88 NonePCN89 Abbott Laboratories, Abbott Park, IL, USAPCN90 Mundipharma, Hoevelaken, NetherlandsPCN91 Roche Farmaceutica Quimica, Amadora, PortugalPCN92 Novartis, Moscow, RussiaPCN93 Pfizer Poland, Warsaw, PolandPCN94 IMS Health , Alexandria , VA, USAPCN95 Roche Products Pty Ltd., Dee Why, AustraliaPCN96 Roche Hong Kong, Hong Kong, Hong KongPCN97 NonePCN98 Novartis Pharma AG, Basel, SwitzerlandPCN99 Amgen GmbH, Zug, SwitzerlandPCN100 Janssen-Cilag Ltd., Buckinghamshire, UKPCN101 NonePCN102 Bayer Healthcare Pharmaceuticals, Inc., Wayne, NJ, USAPCN103 NonePCN104 Roche Brazil, Sao Paulo, BrazilPCN105 Genentech Inc, San Francisco, CA, USA</p><p>A576 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) A 5 7 6 - A 5 8 6</p><p>Copyright 2012, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.</p></li><li><p>PCN106 NonePCN107 Pfizer GmbH, Berlin, GermanyPCN108 Eisai, Woodcliff Lake, NJ, USAPCN109 FFG-sterreichische Forschungsfrderungsgesellschaft, Wien, AustriaPCN110 Canadian Cancer Society Research Institute, Toronto, ON, Canada; National</p><p>Institute of Health, Bethesda, MD, USAPCN111 Ontario Institute for Cancer Research, Toronto, ON, CanadaPCN112 NonePCN113 Genentech, South San Francisco, CA, USAPCN114 Millennium Pharmaceuticals, Inc, Cambridge, MA, USAPCN115 NonePCN116 Janssen Pharmaceutica N.V., Beerse, BelgiumPCN117 Fresenius Biotech GmbH, Munchen, GermanyPCN118 Amgen (Europe) GmbH, Zug, SwitzerlandPCN119 NonePCN120 Janssen Pharmaceutica, Beerse, BelgiumPCN121 Janssen Pharmaceutica N.V., Beerse, BelgiumPCN122 Amgen, Thousand Oaks, CA, USAPCN123 Genentech, Inc., South San Francisco, CA, USAPCN124 National Science Centre, Cracov, PolandPCN125 National Science Centre, Cracov, PolandPCN126 ZONMW, Den Haag, Netherlands; Janssen, Tilburg, NetherlandsPCN127 Health Care Insurance Board, Diemen, NetherlandsPCN128 NonePCN129 NonePCN130 NonePCN131 NonePCN132 Astrazeneca, Luton, UKPCN133 NonePCN134 NonePCN135 IMS Health, PARIS, FrancePCN136 Novartis Pharmaceuticals Canada, Dorval, QC, CanadaPCN137 IMS Health, London, UKPCN138 Sanofi, Bridgewater, NJ, USAPCN139 Ipsen Pharma SAS, Boulogne-Billancourt, FrancePCN140 Janssen Pharmaceutica, Beerse, BelgiumPCN141 Amgen BV, Breda, NetherlandsPCN142 NonePCN143 Sanofi, Guildford, UKPCN144 Costello Medical Consulting Ltd, Cambridge, UKPCN145 NonePCN146 NonePCN147 NonePCN148 Eli Lilly and Company, Indianapolis, IN, USAPCN149 Astellas Pharma Global Development, Leiderdorp, NetherlandsPCN150 NonePCN151 NonePCN152 German Association of Research-based Pharmaceutical Companies (vfa),</p><p>Berlin, GermanyPCN153 Oncotyrol, Innsbruck, AustriaPCN154 NonePCN155 NonePCN156 NonePCN157 NonePCN158 Cancer Care Ontario, Toronto, ON, Canada; Ontario Ministry of Health &amp;</p><p>Long Term Care, Toronto, ON, Canada; Ontario Institute for CancerResearch, Toronto, ON, Canada</p><p>PCN159 Bristol Myers Squibb, Sao Paulo, BrazilPCV1 NonePCV2 NonePCV3 Merck, Whitehouse Station, NJ, USAPCV4 St.Lukes Life Science Institute, Tokyo, JapanPCV5 NonePCV6 NonePCV7 National Institute for Health Research, Southampton, UKPCV8 Eli Lilly and Company, Indianapolis, IN, USA; Daiichi Sankyo Company,</p><p>Limited, Parsippany, NJ, USAPCV9 NonePCV10 NonePCV11 The Health Council of The Netherlands, The Hague, NetherlandsPCV12 Novartis Pharma AG, Basel, SwitzerlandPCV13 LA-SER Europe Ltd., London, UKPCV14 Daiichi Sankyo, Parsippany, NJ, USAPCV15 Bristol-Myers Squibb, Rueil-Malmaison, FrancePCV16 NonePCV17 Bristol-Myers Squibb, Rueil-Malmaison, FrancePCV18 NonePCV19 NonePCV20 NonePCV21 NonePCV22 None</p><p>PCV23 NonePCV24 BERLIN-CHEMIE, Moscow, RussiaPCV25 Eli Lilly and Company, Indianapolis, IN, USA; Daiichi Sankyo Company,</p><p>Limited , Parsippany, NJ, USAPCV26 AstraZeneca Pharmaceuticals, Moscow, RussiaPCV27 NonePCV28 Bristol-Myers Squibb, Rueil-Malmaison, France; Pfizer, Paris, FrancePCV29 Pfizer, Alcobendas, SpainPCV30 Abbott Vascular, Diegem, BelgiumPCV31 Ministry of Science and Environmental Protection of the Republic of Serbia ,</p><p>Belgrade, Serbia and MontenegroPCV32 NonePCV33 NonePCV34 Eli Lillly Company Turkey, Istanbul, TurkeyPCV35 Amgen, Munchen, GermanyPCV36 Actavis Deutschland GmbH &amp; Co. KG , Munchen, GermanyPCV37 Bristol Myers Squibb, Sao Paulo, BrazilPCV38 The Medicines Company, Parsippany, NJ, USAPCV39 Pfizer, Mexico, Mexico; Bristol-Myers Squibb, Mexico, MexicoPCV40 NonePCV41 Bayer HealthCare, Moscow, RussiaPCV42 Bayer HealthCare, Moscow, RussiaPCV43 NonePCV44 Novartis, Hellas, GreecePCV45 AstraZeneca Turkey, Istanbul, TurkeyPCV46 Bayer HealthCare Pharmaceuticals, Moscow, RussiaPCV47 The Health Council of The Netherlands, The Hague, NetherlandsPCV48 Janssen Pharmaceuticals, Inc., Raritan, NJ, USAPCV49 Bayer, Athens, GreecePCV50 AstraZeneca, Wanchai, Hong KongPCV51 Bayer HealthCare AG, Wuppertal, GermanyPCV52 Merck, Sharp &amp; Dohme, Paco de Arcos, PortugalPCV53 Novartis, Hellas, Greece; Novartis, Hellas, GreecePCV54 Bayer, Athens, GreecePCV55 SERVIER ILA A.S., Istanbul, TurkeyPCV56 MSD, Sao Paolo City, BrazilPCV57 NonePCV58 NonePCV59 Medical Research Council, London, UK; National Institute for Health</p><p>Research, London, UKPCV60 NonePCV61 Berlin-Chemie, Moscow, RussiaPCV62 ZAO Corporation OLIFEN, Moscow, RussiaPCV64 AstraZeneca, Brussels, BelgiumPCV65 Abbott Laboratories, Allschwil, SwitzerlandPCV66 Nycomed: A Takeda Company, Mexico, Mexico City, MexicoPCV67 Engineering and Physical Sciences Research Council (EPSRC), Swindon, UKPCV68 GlaxoSmithKline, Madrid, SpainPCV69 FERRER-inCode, Barcelona, SpainPCV70 Pfizer Nederland, Capelle aan den Ijssel, NetherlandsPCV71 NonePCV72 Bayer Healthcare, Barcelona, SpainPCV73 Bayer, Bratislava, Slovak RepublicPCV74 FERRER-inCode, Barcelona, SpainPCV75 Bayer Pharma AG, Berlin, GermanyPCV76 AstraZeneca SpA, Milano, ItalyPCV77 Nestle Health Science, Lutry, SwitzerlandPCV79 Boehringer Ingelheim Pty Limited, Sydney, AustraliaPCV80 Novartis, Seoul, South KoreaPCV81 Care For Your Heart, Hong Kong, Hong KongPCV82 Novartis Hellas, Metamorfosis, GreecePCV83 NonePCV84 NonePCV85 NonePCV86 Kantar Health, New York, NY, USAPCV87 NonePCV88 Bayer HealthCare Pharmaceuticals, Wuppertal, GermanyPCV89 Netherlands Organisation for Health Research and Development (ZonMw),</p><p>The Hague, NetherlandsPCV90 Novartis Pharmaceuticals, Basel, SwitzerlandPCV91 Sanofi Aventis S.A., Barcelona, SpainPCV92 NonePCV93 NonePCV94 Boehringer Ingelheim Pharma GmbH &amp; Co. KG, Ingelheim, GermanyPCV95 Novartis Pharma AG, Basel, SwitzerlandPCV96 Novartis Pharma AG, Basel, SwitzerlandPCV97 Bayer Yakuhin, Ltd., Tokyo, JapanPCV98 Novartis Farmaceutica, Barcelona, SpainPCV99 Health Institute Carlos III, Madrid, SpainPCV100 Kantar Health, Princeton, NJ, USAPCV101 Bayer Yakuhin, Ltd., Tokyo, Japan</p><p>ReferenceCode Financial Support</p><p>ReferenceCode Financial Support</p><p>A577V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) A 5 7 6 - A 5 8 6</p></li><li><p>PCV102 Bayer Yakuhin Ltd., Tokyo, JapanPCV103 Pfizer, Madrid, SpainPCV104 NonePCV105 MSD, Hoddesdon, UKPCV106 Novartis Pharma, Cairo, EgyptPCV107 TEVA, Wilrijk, BelgiumPCV108 Ministry of Science and Higher Education, Warsaw, Poland; Jagiellonian</p><p>University, Krakow, PolandPCV109 Bayer HealthCare Pharmaceuticals, Berlin, GermanyPCV110 Daiichi Sankyo, Parsippany, NJ, USAPCV111 Sanofi, Chilly-Mazarin, FrancePCV112 NonePCV113 NonePCV114 NonePCV115 Kantar Health GmbH, Munchen, GermanyPCV116 RQRUM, Montreal, QC, Canada; Pfizer, Montreal, QC, Canada; sanofi-aventis,</p><p>laval, QC, CanadaPCV117 Italian Medicines Agency, Rome, ItalyPCV118 NonePCV119 NonePCV120 NonePCV121 Novartis Farmaceutica, S.A., Barcelona, SpainPCV122 NonePCV123 Bristol Myers Squibb, Sao Paulo, BrazilPDB1 sanofi-aventis U.S., Bridgewater, NJ, USAPDB2 Bristol Myers Squibb, Wallingford, CT, USAPDB3 sanofi-aventis U.S., Bridgewater, NJ, USAPDB4 Takeda Pharmaceuticals International, Inc., Deerfield, IL, USAPDB5 sanofi-aventis U.S., Bridgewater, NJ, USAPDB6 sanofi-aventis U.S., Bridgewater, NJ, USAPDB7 Eli Lilly &amp; Company, Indianapolis, IN, USAPDB8 Bristol-Myers Squibb, Princeton, NJ, USAPDB9 NonePDB10 Novartis Pharma AG, Basel, SwitzerlandPDB11 NonePDB12 NonePDB13 Novartis, Rueil Malmaison, FrancePDB14 NonePDB15 Boehringer Ingelheim GmbH, Ingelheim, GermanyPDB16 NonePDB17 European Commission, Brussels, BelgiumPDB18 AstraZeneca pharmaceuticals LP, Wilmington, DE, USA; Bristol-Myers Squibb</p><p>, Pennington, NJ, USAPDB19 Novo Nordisk Ltd, Crawley, UKPDB20 NonePDB21 Novartis, East Hanover, NJ, USAPDB22 Boehringer-ingelheim, Paris, FrancePDB23 NonePDB24 Pfizer S.L.U., Madrid, SpainPDB25 NonePDB26 NonePDB27 The Society of Endocrinology and Metabolism of Turkey, Istanbul, TurkeyPDB28 The Society of Endocrinology and Metabolism of Turkey, Istanbul, TurkeyPDB29 MSD Italia Srl, Rome, ItalyPDB30 NonePDB31 The Society of Endocrinology and Metabolism of Turkey, Istanbul, TurkeyPDB32 National Science Centre, Cracov, PolandPDB33 Merck SL, Madrid, SpainPDB34 Ontario Ministry of Health, Toronto, ON, CanadaPDB35 Novo Nordisk, Zurich, SwitzerlandPDB36 Novo Nordisk, Zurich, SwitzerlandPDB37 Eli Lilly and Company, Indianapolis, IN, USAPDB38 NovoNordisk, Warsaw, PolandPDB39 Novo Nordisk, Zurich, SwitzerlandPDB40 Janssen Global Services, LLC, Ratitan, NJ, USAPDB41 Novo Nordisk, Zurich, SwitzerlandPDB42 Novo Nordisk, Zurich, SwitzerlandPDB43 Novartis, Hellas, GreecePDB44 Novo Nordisk, Zurich, SwitzerlandPDB45 Novartis, Basel, SwitzerlandPDB46 Merck, Sharp &amp; Dohme, Paco de Arcos, PortugalPDB47 Novo Nordisk, Copenhagen, SwedenPDB48 Novartis Canada, Montreal, QC, CanadaPDB49 Novartis Canada, Dorval, QC, CanadaPDB50 Novartis Canada, Dorval, QC, CanadaPDB51 Novartis Pharmaceuticals Canada, Dorval, QC, CanadaPDB52 Novo Nordisk, Princeton, NJ, USAPDB53 Novartis, Hellas, Greece; Novartis, Hellas, GreecePDB54 IMS Health, London, UKPDB55 Pfizer, Inc, New York, NY, USAPDB56 Takeda Pharmaceuticals, Deerfield, IL, USA</p><p>PDB57 Boehringer Ingelheim, Ingelheim am Rhein, GermanyP...</p></li></ul>


View more >